Italia markets close in 1 hour 53 minutes

Quantel (0FRI.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
11,48-9,42 (-45,07%)
Al 05:09PM BST. Mercato aperto.
Schermo intero
Chiusura precedente20,90
Aperto17,14
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno17,14 - 17,14
Intervallo di 52 settimane17,14 - 17,14
Volume448
Media VolumeN/D
Capitalizzazione180,937M
Beta (5 anni mensile)N/D
Rapporto PE (ttm)59,48
EPS (ttm)N/D
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    LUMIBIRD: 12% REVENUE GROWTH FOR THE FIRST QUARTER OF 2022

    Lannion, April 25, 2022 – 5:45 pm 12% REVENUE GROWTH FOR THE FIRST QUARTER OF 2022 The LUMIBIRD Group, the European leader for laser technologies, recorded 12% growth in consolidated revenues for the first quarter of 2022, up to €38.0m. Like-for-like and at constant exchange rates, this growth equates to 11%. This performance follows on from 2021, which saw revenue growth (compared to pro forma 2020) of +11%. Consolidated revenues (unaudited) Revenues (€m)20222021ChangeFirst quarter38.033.8+12%o

  • GlobeNewswire

    LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON MAY 3, 2022

    Lannion, March 28, 2022 – 6:30pm LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON MAY 3, 2022 LUMIBIRD’s shareholders are informed that they are invited to take part in the Combined General Meeting to be held on Tuesday May 3, 2022 from 2:00pm (CET) at 2-bis avenue du Pacifique, ZA de Courtabœuf, Les Ulis (91), France. The meeting notice containing the agenda, the text of the resolutions and the main conditions for taking part in and voting at the General Meeting was

  • GlobeNewswire

    LUMIBIRD 2021 EARNINGS: INITIAL TARGET ACHIEVED FOR AN EBITDA/REVENUE RATIO OF OVER 20%

    Lannion, March 17, 2022 – 5:45pm 2021 EARNINGS: INITIAL TARGET ACHIEVED FOR AN EBITDA/REVENUE RATIO OF OVER 20% EBITDA up 25% proforma to €32.6m (20.1% of revenues)Continued increase in profitability for the Medical division, driven by the successful integration of EllexFinancial position adapted to the growth strategy The LUMIBIRD Group, the European leader for laser technologies, achieved an EBITDA/revenue ratio of 20.1% in 2021, within the target range of 20% to 25%. This performance was supp